Oxidized LDL and thickness of carotid intima-media are associated with coronary atherosclerosis in middle-aged men: lower levels of oxidized LDL with statin therapy

Atherosclerosis. 2001 Apr;155(2):403-12. doi: 10.1016/s0021-9150(00)00573-6.

Abstract

We investigated the relation between serum lipids including oxidized LDL and the severity of coronary atherosclerosis. Serum lipids and oxidized LDL was measured in 62 men (33-66 years), who underwent diagnostic coronary angiography and sonography to measure the carotid intima-media thickness. LDL oxidation was found in chemical analyses to be due to conjugated fatty acids in cholesteryl esters and triglycerides. Regression analysis indicated that the carotid intima-media thickness and the ratio of LDL diene conjugation to LDL cholesterol (the ox-LDL:LDL ratio) were the only factors associated independently with the severity of coronary atherosclerosis. The patients with multi-vessel disease who did not use lipid lowering therapy had a 50% thicker carotid intima media (P = 0.030) and a 41% higher ox-LDL:LDL ratio (P = 0.020) than patients with normal vessels. Further, patients with multi-vessel disease on statin therapy had a 24% lower ox-LDL:LDL ratio than the subjects with multi-vessel disease who did not use lipid lowering drugs (P = 0.027), although the concentration of LDL cholesterol did not differ between the groups. This study supports the hypothesis that lipid oxidation plays a role in the development of atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anticholesteremic Agents / pharmacology
  • Anticholesteremic Agents / therapeutic use*
  • Cardiovascular Agents / pharmacology
  • Cardiovascular Agents / therapeutic use
  • Carotid Arteries / pathology*
  • Cholesterol Esters / blood
  • Comorbidity
  • Coronary Angiography
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / pathology*
  • Coronary Vessels / diagnostic imaging
  • Fatty Acids / blood
  • Feeding Behavior
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Lipids / blood
  • Lipoproteins, LDL / blood*
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Oxidative Stress
  • Triglycerides / blood
  • Tunica Intima / pathology*
  • Tunica Media / pathology*
  • Ultrasonography

Substances

  • Anticholesteremic Agents
  • Cardiovascular Agents
  • Cholesterol Esters
  • Fatty Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids
  • Lipoproteins, LDL
  • Triglycerides
  • oxidized low density lipoprotein